0.32
+0.0089(+2.84%)
Currency In USD
Address
1180 Seminole Trail
Charlottesville, VA 22901
United States of America
Phone
434 422 9800
Website
Sector
Healthcare
Industry
Biotechnology
Employees
5
First IPO Date
July 27, 2018
| Name | Title | Pay | Year Born |
| Mr. Cary John Claiborne MBA | Chief Executive Officer, President & Director | 561,331 | 1961 |
| Mr. Tony Goodman | Chief Operating Officer & Director | 342,828 | 1964 |
| Mr. Vinay Shah A.C.A., M.B.A. | Chief Financial Officer & Treasurer | 0 | 1963 |
| Mr. John R. Martin J.D. | Chief Legal Officer | 0 | N/A |
| Mr. Abel Svitavsky CPA | Controller | 0 | N/A |
| Dr. Brigitte Robertson M.D. | Acting Chief Medical Officer | 0 | 1964 |
| Andrew Taubman | Vice President of Corporate Development | 0 | N/A |
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.